Press release
Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market Emerges as a Core Driver of the Lisinopril Market in 2025
Lisinopril
What Is the Expected CAGR for the Lisinopril Market Through 2025?
A significant expansion has been observed recently within the lisinopril market, projecting an ascent from its 2024 valuation of $1.76 billion to $1.87 billion by 2025, reflecting a compound annual growth rate of 6.4%; this historical upward trajectory is mainly powered by broader availability, evolving lifestyle patterns, enhanced proactive health checks, greater ease in obtaining generic forms of lisinopril, and improved patient compliance with treatment regimens.
What's the Projected Size of the Global Lisinopril Market by 2029?
Anticipation is for substantial expansion within the lisinopril market across the forthcoming years, with its valuation projected to ascend to $2.35 billion by the year 2029, fueled by a compound annual growth rate (CAGR) of 5.9%. This upward trajectory during the projection timeframe stems from several key factors: an increasing incidence of hypertension and cardiovascular ailments, the accessibility and favorable pricing of generic alternatives, heightened public knowledge alongside earlier disease identification, a surging need for efficacious therapeutic options, and the demographic shift towards an older population. Furthermore, dominant patterns shaping this period involve advancements in how the medication is administered, the imperative for superior and more personalized drug delivery methodologies, the requirement for economical solutions, the need for robust treatments specifically targeting heart failure, and the demand for efficacious interventions against diabetic kidney disease.
View the full report here:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report
Top Growth Drivers in the Lisinopril Industry: What's Accelerating the Market?
The escalating incidence of ailments related to the heart and circulatory system is anticipated to fuel the expansion of the lisinopril market moving ahead. As a class of conditions impacting the heart and blood vessels, cardiovascular diseases (CVDs) are becoming more widespread, a trend linked to several societal shifts, including demographic expansion and an aging populace, alongside persistent modifiable risk factors and insufficient uptake of established preventative and therapeutic protocols. Lisinopril serves as a key treatment in managing these conditions principally by effectively decreasing blood pressure, thereby alleviating stress on both the cardiac muscle and the kidneys; its mechanism involves blocking the synthesis of angiotensin II, which promotes wider blood vessels, lowers circulating blood volume, and offers protective benefits to vital organs. To illustrate this critical public health concern, data from the Singapore Heart Foundation (SHF), a local non-profit, indicated that ischemic heart diseases accounted for 5,302 fatalities in May 2024, marking a marginal rise from the 5,290 deaths recorded in 2022, underscoring why the increasing burden of cardiovascular pathology is a major impetus for the lisinopril market's advancement.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp
What Are the Main Segments in the Lisinopril Market?
The lisinoprilmarket covered in this report is segmented -
1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
3) By Dosage: Tablet; Liquid; Other Dosages
4) By Population Type: Children; Adults
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Zestoretic: Different Dosage Forms; Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms; Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms; Generic Versions Of Zestril
4) By Other Brands: International Brand Variants; Combination Drug Formulations
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp
Which Top Companies are Driving Growth in the Lisinopril Market?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences
Which Regions Will Dominate the Lisinopril Market Through 2029?
North America was the largest region in the lisinopril market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16465
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market Emerges as a Core Driver of the Lisinopril Market in 2025 here
News-ID: 4277108 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Lisinopril
Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market : Pivot …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Lisinopril Market Size Growth Forecast: What to Expect by 2025?
The market size of lisinopril has been expanding robustly in the past few years. This market is projected to boost from $1.76 billion in 2024 to $1.88 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.…
Lisinopril Market Report 2025-2034: Industry Overview, Trends, And Forecast Anal …
The Lisinopril Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Lisinopril Market Size and Its Estimated Growth Rate?
The lisinopril market has seen substantial growth in recent years. It is projected to grow from $1.76 billion in 2024 to $1.88 billion in…
Emerging Lisinopril Market Outlook Trend 2025-2034:
How Is the Lisinopril Market Projected to Grow, and What Is Its Market Size?
The market size for Lisinopril has seen a robust growth in the past few years. It is projected to increase from $1.76 billion in 2024 to $1.88 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.7%. This progress in the historical timeframe can be credited to factors such as improved accessibility, alterations in lifestyle,…
Lisinopril Market Sees Growth Amid Rising Incidences of Hypertension and Cardiov …
"Global Lisinopril Market, By Disease (Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Others), Dosage (Tablet, Liquid, Others), Dosage Strength (10mg/12.5mg, 20mg/12.5mg, 20mg/25mg, Others), Brand (Zestoretic, Prinivil, Zestril, Others), Population Type (Children, Adults), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) - Industry Trends and Forecast to 2031.
Data Bridge Market Research analyses that the global lisinopril market which was…
Lisinopril Market Size, Share Analysis And Trends Report 2024 To 2033
The Business Research Company recently released a comprehensive report on the Global Lisinopril Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of…
Lisinopril Global Market Analysis, Trends, Growth, Research And Forecast 2033
The new report published by The Business Research Company, titled Lisinopril Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the lisinopril market size has grown strongly in recent years. It will grow from $1.66 billion in 2023 to $1.76…
